Atlas Trials

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

Clinical trial NCT05098613 · RECRUITING

Trial details

NCT number
NCT05098613
Sponsor
University of Colorado, Denver
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)CNS Lymphoma
Start date
2021-12-21
Primary completion
2026-12-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.